#Sweden #Gothenburg #Zinzino #Health #Sanki

Zinzino Expands Its Reach by Acquiring Sanki

In a strategic move to enhance its presence in the health and wellness market, Zinzino AB has announced its acquisition of the Mexican direct sales company Sanki. This agreement, unveiled on November 8, 2025, involves the purchase of Sanki’s distributor database, customer register, and inventory, along with the associated intellectual property rights. By acquiring 100% of Sanki’s subsidiaries in Colombia and Peru, Zinzino is set to significantly increase its distribution capabilities in these promising markets.

Zinzino, headquartered in Gothenburg, Sweden, is focused on delivering innovative biotechnology solutions aimed at improving individuals' health and well-being. With this acquisition, the company aims to integrate Sanki's distinctive, trademarked product portfolio into its unique test-based product concept. Notably, Sanki has carved out a niche in the health segment, particularly in North America and South America, boasting a diverse range of patented health products and an annual turnover estimated at $12 million.

The acquisition, which is scheduled to finalize on January 1, 2026, requires a total payment of $8 million. In a significant departure from conventional purchase agreements, $7 million of the payment will be made through newly issued Zinzino shares, while the remaining $1 million will be paid in cash from Zinzino’s reserves. Furthermore, the deal includes additional payments that may reach up to $12 million, contingent on future sales developments, all of which will also be settled through newly issued shares.

Strategic Growth

Dag Bergheim Pettersen, CEO of Zinzino, expressed enthusiasm regarding the partnership with Sanki. He emphasized the significance of individual advice and customized solutions, not only in health and wellness but across various sectors. Alongside Alejandro Lopez Tello, CEO and co-founder of Sanki, the two executives bring a wealth of industry experience to the table, setting the stage for a strong collaborative effort. Pettersen highlighted the intent to drive a modern, personalized shopping experience through direct sales, setting Zinzino on a path of sustainable growth.

Zinzino's acquisition of Sanki is part of a broader strategy that has seen the company expand its portfolio through previous purchases—including VMA Life in 2020, Enhanzz in 2022, and more recently, multiple companies in 2025 such as Zurvita and Valentus. This consistent approach to acquiring target companies aligns with Zinzino's goal to enhance its distribution power, better serve its customer base, and expand into new consumer areas.

By leveraging Sanki’s network and resources, Zinzino anticipates a boost in efficiency and profitability, as both brands harness synergies from their combined operations. The integration of Sanki’s innovative products with Zinzino’s testing methodologies promises to deliver comprehensive and tailored solutions designed for health-conscious consumers.

Looking Ahead

As Zinzino forges ahead with this acquisition, it is poised to not only fortify its existing markets but also to expand into burgeoning areas within the health sector. With a commitment to technological innovation and personalized health solutions, Zinzino is setting a robust foundation for future growth. The collaboration with Sanki is expected to be a catalysts for mutual success, driven by a strong alignment in vision and operational strategies.

As health and wellness continue to occupy a pivotal role in consumer trends, Zinzino’s proactive steps are likely to resonate positively in the market, offering new possibilities for consumers looking for reliable and tailored health solutions. The company's journey is a testament to the evolving landscape of health and nutrition, where personalized approaches are becoming increasingly paramount.